Shopping Cart
- Remove All
- Your shopping cart is currently empty
IRAK4-IN-22 is a selective, orally active, potent IRAK4 inhibitor that acts on IRAK4 (IC50: 3 nM) and TAK1 (IC50: 17 nM). IRAK4-IN-21 exhibits potent inhibition of IL-23 production with an IC50 value of 0.10 μM. IRAK4-IN-21 can be used to study autoimmune diseases, such as plaque psoriasis and psoriatic arthritis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,400 | 6-8 weeks | |
50 mg | $1,820 | 6-8 weeks | |
100 mg | $2,820 | 6-8 weeks |
Description | IRAK4-IN-22 is a selective, orally active, potent IRAK4 inhibitor that acts on IRAK4 (IC50: 3 nM) and TAK1 (IC50: 17 nM). IRAK4-IN-21 exhibits potent inhibition of IL-23 production with an IC50 value of 0.10 μM. IRAK4-IN-21 can be used to study autoimmune diseases, such as plaque psoriasis and psoriatic arthritis. |
Molecular Weight | 513.57 |
Formula | C28H28FN7O2 |
Cas No. | 2170694-05-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.